Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) Net Margin (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Net Margin for 6 consecutive years, with 2750.62% as the latest value for Q4 2018.

  • Quarterly Net Margin rose 1440062.0% to 2750.62% in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 1833.66% through Dec 2018, up 1435192.0% year-over-year, with the annual reading at 455.45% for FY2025, 49961.0% down from the prior year.
  • Net Margin hit 2750.62% in Q4 2018 for Armata Pharmaceuticals, up from 529.97% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 8765.69% in Q2 2015 to a low of 43181.82% in Q4 2016.
  • Historically, Net Margin has averaged 7667.36% across 5 years, with a median of 4563.21% in 2016.
  • Biggest five-year swings in Net Margin: skyrocketed 162981197bps in 2014 and later crashed -4069744bps in 2016.
  • Year by year, Net Margin stood at 984.16% in 2014, then tumbled by -152bps to 2484.38% in 2015, then crashed by -1638bps to 43181.82% in 2016, then surged by 73bps to 11650.0% in 2017, then surged by 124bps to 2750.62% in 2018.
  • Business Quant data shows Net Margin for ARMP at 2750.62% in Q4 2018, 529.97% in Q3 2018, and 1085.41% in Q2 2018.